+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Shingles Drug"

Herpes Zoster Treatment - Global Strategic Business Report - Product Thumbnail Image

Herpes Zoster Treatment - Global Strategic Business Report

  • Report
  • October 2024
  • 381 Pages
  • Global
From
Shingles - Pipeline Insight, 2024 - Product Thumbnail Image

Shingles - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 80 Pages
  • Global
From
Herpes Zoster - Pipeline Insight, 2024 - Product Thumbnail Image

Herpes Zoster - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 85 Pages
  • Global
From
From
From
From
Shingles - Epidemiology Forecast - 2032 - Product Thumbnail Image

Shingles - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Herpes Zoster - Epidemiology Forecast to 2032 - Product Thumbnail Image

Herpes Zoster - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Herpes Zoster Therapeutics Market 2022-2026 - Product Thumbnail Image

Herpes Zoster Therapeutics Market 2022-2026

  • Report
  • March 2022
  • 120 Pages
  • Global
From
Antiviral Therapeutics - Technologies, Markets & Companies - Product Thumbnail Image

Antiviral Therapeutics - Technologies, Markets & Companies

  • Report
  • November 2021
  • 620 Pages
  • Global
From
  • 17 Results (Page 1 of 1)
Loading Indicator

The Shingles Drug market is a subset of the Infectious Diseases Drugs market. It is composed of drugs used to treat shingles, a viral infection caused by the varicella-zoster virus. Symptoms of shingles include a painful rash, blisters, fever, and fatigue. Treatment typically involves antiviral medications, such as acyclovir, valacyclovir, and famciclovir. These drugs can reduce the severity and duration of the infection, as well as reduce the risk of complications. The Shingles Drug market is highly competitive, with a number of large pharmaceutical companies offering products. These include GlaxoSmithKline, Merck & Co., Pfizer, Novartis, and Sanofi. Additionally, there are several smaller companies that specialize in the development of shingles drugs, such as ViroPharma, Valeant Pharmaceuticals, and Cipla. Show Less Read more